These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33860040)

  • 1. The Relationship between Hepatic Myeloid-Derived Suppressor Cells and Clinicopathological Parameters in Patients with Chronic Liver Disease.
    Zhou Z; Lai P; Zhang S; Wang Y; Qu N; Lu D; Gao L; Xu L; Yang Y; Zhang T; Sun X; Zheng X; Liu Y; Liang H; Chen S
    Biomed Res Int; 2021; 2021():6612477. PubMed ID: 33860040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammation.
    Zhang H; Lian M; Zhang J; Bian Z; Tang R; Miao Q; Peng Y; Fang J; You Z; Invernizzi P; Wang Q; Gershwin ME; Ma X
    Hepatology; 2018 Jan; 67(1):232-246. PubMed ID: 28777871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-35 Regulates Immune Microenvironment of Autoimmune Hepatitis Through Inducing the Expansion of Myeloid-Derived Suppressor Cells.
    Lian M; Zhang J; Zhao L; Chen X; Peng Y; Wang Q; Chen S; Ma X
    Front Immunol; 2019; 10():2577. PubMed ID: 31787974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid-derived suppressor cells expansion is closely associated with disease severity and progression in HBV-related acute-on-chronic liver failure.
    Zeng Y; Li Y; Xu Z; Gan W; Lu L; Huang X; Lin C
    J Med Virol; 2019 Aug; 91(8):1510-1518. PubMed ID: 30905084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD33
    Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
    Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
    Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
    J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD45
    Mao FY; Zhao YL; Lv YP; Teng YS; Kong H; Liu YG; Wu XL; Hao CJ; Chen W; Duan MB; Han B; Ma Q; Wang TT; Peng LS; Zhang JY; Cheng P; Su CY; Fu XL; Zou QM; Guo G; Guo XL; Zhuang Y
    Cell Death Dis; 2018 Jul; 9(7):763. PubMed ID: 29988030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical and prognostic significance of CD14(+)HLA-DR(-/low) myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy.
    Wang D; An G; Xie S; Yao Y; Feng G
    Tumour Biol; 2016 Aug; 37(8):10427-33. PubMed ID: 26846107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
    Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
    Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct alterations of CD68
    Shao X; Wu B; Cheng L; Li F; Zhan Y; Liu C; Ji L; Min Z; Ke Y; Sun L; Chen H; Cheng Y
    J Transl Med; 2018 Mar; 16(1):48. PubMed ID: 29499727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and Implications of myeloid-derived suppressor cells and lymphocyte subsets in Egyptian patients with hepatitis C virus-related hepatocellular carcinoma.
    Hetta HF; Zahran AM; Mansor SG; Abdel-Malek MO; Mekky MA; Abbas WA
    J Med Virol; 2019 Jul; 91(7):1319-1328. PubMed ID: 30761547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid-derived suppressor cells ameliorate liver mitochondrial damage to protect against autoimmune hepatitis by releasing small extracellular vesicles.
    Shen M; Fan X; Shen Y; Wang X; Wu R; Wang Y; Huang C; Zhao S; Zheng Y; Men R; Luo X; Yang L
    Int Immunopharmacol; 2023 Jan; 114():109540. PubMed ID: 36516541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High numbers of myeloid derived suppressor cells in peripheral blood and ascitic fluid of cirrhotic and HCC patients.
    Elwan N; Salem ML; Kobtan A; El-Kalla F; Mansour L; Yousef M; Al-Sabbagh A; Zidan AA; Abd-Elsalam S
    Immunol Invest; 2018 Feb; 47(2):169-180. PubMed ID: 29182438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and significance of peripheral myeloid-derived suppressor cells in chronic hepatitis B patients.
    Lv Y; Cui M; Lv Z; Lu J; Zhang X; Zhao Z; Wang Y; Gao L; Tsuji NM; Yan H
    Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):462-469. PubMed ID: 29753730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD205
    Fu C; Fu Z; Jiang C; Xia C; Zhang Y; Gu X; Zheng K; Zhou D; Tang S; Lyu S; Ma S
    Cancer Sci; 2021 Mar; 112(3):1011-1025. PubMed ID: 33368883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
    Li F; Zhao Y; Wei L; Li S; Liu J
    Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD11b
    Nachmany I; Bogoch Y; Sivan A; Amar O; Bondar E; Zohar N; Yakubovsky O; Fainaru O; Klausner JM; Pencovich N
    FASEB J; 2019 May; 33(5):5967-5978. PubMed ID: 30730772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic and functional alterations of myeloid-derived suppressor cells during the disease course of multiple sclerosis.
    Iacobaeus E; Douagi I; Jitschin R; Marcusson-Ståhl M; Andrén AT; Gavin C; Lefsihane K; Davies LC; Mougiakakos D; Kadri N; Le Blanc K
    Immunol Cell Biol; 2018 Sep; 96(8):820-830. PubMed ID: 29569304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Immunobiology of Receptor Activator for Nuclear Factor Kappa B Ligand and Myeloid-Derived Suppressor Cell Activation in Immunoglobulin G4-Related Sclerosing Cholangitis.
    Lian M; Wang Q; Jiang X; Zhang J; Wei Y; Li Y; Li B; Chen W; Zhang H; Miao Q; Peng Y; Xiao X; Sheng L; Zhang W; Fang J; Tang R; Gershwin ME; Ma X
    Hepatology; 2018 Nov; 68(5):1922-1936. PubMed ID: 29774578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoplasmic reticulum stress induced LOX-1
    Nan J; Xing YF; Hu B; Tang JX; Dong HM; He YM; Ruan DY; Ye QJ; Cai JR; Ma XK; Chen J; Cai XR; Lin ZX; Wu XY; Li X
    Immunology; 2018 May; 154(1):144-155. PubMed ID: 29211299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.